Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Genetic Predisposition of Individuals Who Aggravated by Embolism in COVID-19 Positive Patients

NCT04910360 is registered in ClinicalTrials.gov with Afyonkarahisar Health Sciences University as lead sponsor.

NCT NCT04910360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04910360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Genetic Predisposition of Individuals Who Aggravated by Embolism in COVID-19 Positive Patients
Lead sponsor
Afyonkarahisar Health Sciences University
Phase
Observational
Overall status
Unknown status
Start date
March 5, 2021
Completion date
August 30, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, embolism, genetic predisposition